Verapamil Hydrochloride
42 NDCs across 10 manufacturers|42 Generic,0 Brand
Verapamil Hydrochloride is used to treat variant angina pectoris, atrial fibrillation, atrial flutter, hypertension, myocardial infarction and supraventricular tachycardia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Nov 12, 1985. FDA's Orange Book lists 23 AB-rated (therapeutically equivalent) products for this ingredient.
Verapamil Hydrochloride is available as 42 NDCs from 10 manufacturers (42 generic, 0 brand), with NADAC prices from $0.07 to $7.96 per EA — the most expensive product costs about 109× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
42
42G / 0B
Manufacturers
10
competing in market
Price Spread
$0.07 – $7.96
per EA
7d Activity
avg +8.0% WoW · of 42 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Wilshire Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Calcium Channel Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
10 manufacturers producing VERAPAMIL HYDROCHLORIDE
Frequently Asked Questions
What is Verapamil Hydrochloride used to treat?
Verapamil Hydrochloride is used to treat variant angina pectoris, atrial fibrillation, atrial flutter, hypertension, myocardial infarction and supraventricular tachycardia, per the National Library of Medicine's MED-RT classification.
When did Verapamil Hydrochloride become available as a generic?
FDA approved the first generic Verapamil Hydrochloride (ANDA) on Nov 12, 1985. The Orange Book currently lists 23 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Verapamil Hydrochloride products are on the market?
The Verapamil Hydrochloride drug market contains 42 NDCs from 10 manufacturers — 42 generic and 0 brand products.
What is the price range for Verapamil Hydrochloride?
NADAC reference prices for Verapamil Hydrochloride range from $0.0732 to $7.9598 per EA — the most expensive product costs about 109× the cheapest.
Which manufacturers make Verapamil Hydrochloride?
10 manufacturers list Verapamil Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Wilshire Pharmaceuticals Inc. (7), Actavis Pharma, Inc. (7), Nivagen Pharmaceuticals Inc. (5), Glenmark Pharmaceuticals Inc., USA (5), Teva Pharmaceuticals USA Inc. (4).
How has the price of Verapamil Hydrochloride changed recently?
Over the past 7 days, 25 Verapamil Hydrochloride NDCs rose and 10 fell, with a market-wide average change of +8.0%.